SMA 200 spoločnosti NeuroVive Pharmaceutical AB
Aká je hodnota metriky SMA 200 spoločnosti NeuroVive Pharmaceutical AB?
Hodnota metriky SMA 200 spoločnosti NeuroVive Pharmaceutical AB je $0 -7.26%
Aká je definícia metriky SMA 200?
SMA 200 (Simple Moving Average 200) je priemerná cena akcie za posledných 200 dní vypočítaná ako nevážený priemer z predchádzajúcich 200 záverečných cien.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou NeuroVive Pharmaceutical AB
Čomu sa venuje spoločnosť NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy s metrikou sma 200 podobnou spoločnosti NeuroVive Pharmaceutical AB
- Hodnota metriky SMA 200 spoločnosti 8I je AUD$0 -29.63%
- Hodnota metriky SMA 200 spoločnosti Perk Labs je $0 +58.24%
- Hodnota metriky SMA 200 spoločnosti Latecoere S.A je €0 -43.93%
- Hodnota metriky SMA 200 spoločnosti BMG Resources je AUD$0 -52.24%
- Hodnota metriky SMA 200 spoločnosti Aspermont je AUD$0 -77.62%
- Hodnota metriky SMA 200 spoločnosti Athersys Inc je $0 +89.52%
- Hodnota metriky SMA 200 spoločnosti NeuroVive Pharmaceutical AB je $0 -7.26%
- Hodnota metriky SMA 200 spoločnosti Westar Resources je AUD$0 -53.36%
- Hodnota metriky SMA 200 spoločnosti Otto je AUD$0 +1.84%
- Hodnota metriky SMA 200 spoločnosti Celsius Resources je AUD$0 +1.74%
- Hodnota metriky SMA 200 spoločnosti Sunstone Metals je AUD$0 -80.15%
- Hodnota metriky SMA 200 spoločnosti O.A.T je $0 -170.37%
- Hodnota metriky SMA 200 spoločnosti Sultan Resources je AUD$0 -80.77%